The role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment

Basit Öğe Kaydı
dc.authorid0000-0002-6990-1945en_US
dc.contributor.authorİzzettin, Fikret Vehbi
dc.contributor.authorÇelik, Sevda
dc.contributor.authorAcar, Rezzan Deniz
dc.contributor.authorTezcan, Songül
dc.contributor.authorAksoy, Nilay
dc.contributor.authorBektay, Muhammed Yunus
dc.contributor.authorSancar, Mesut
dc.date.accessioned2022-08-09T13:35:11Z
dc.date.available2022-08-09T13:35:11Z
dc.date.issued2019en_US
dc.departmentFakülteler, Eczacılık Meslek Bilimleri Bölümü, Klinik Eczacılık Ana Bilim Dalıen_US
dc.description.abstractABSTRACT: This study was carried out on patients who were under anticoagulation treatment with warfarin, at the outpatient cardiology clinic. The aim was to determine the effectiveness of pharmacist consultation, education, and intervention on each patient’s therapeutic results. A cross-sectional randomized trial has been done. Twenty-five patients were included in the study. The Oral Anticoagulation Knowledge (OAK) Test, Short Form-36 (SF-36) and Duke Anticoagulation Satisfaction Scale (DASS) were applied. Patients resumed their routine anticoagulation treatment and INR and complications were recorded during the study. Additionally, patients received patient education, consultation on lifestyle and anticoagulant usage issues from a pharmacist. The same tests were applied again to the patients on the 90th day of the study and the results were compared with the initial test. Maintenance of INR within the target range and complication rates were compared before and after the intervention. Pre-test and post-test results of the patients revealed statistically significant improvements on the physical and mental score components of the SF-36 (p = 0.001; p = 0.001), OAK test scores (p ≤ 0.001) and the (negative) “limitations” and “burdens” and “positive effects” components of the DASS (p = 0.005; p < 0.001; p = 0.001). The successful maintenance of INR within target range was significantly higher (p = 0.027). The positive effects of pharmacist consultation and education on therapeutic results were demonstrated.en_US
dc.identifier.citationİzzettin F., Çelik S., Acar R., Tezcan S., Aksoy N., Bektay M., Sancar M. (2019). The role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment. Journal of research in pharmacy (online), 23(6), 1157 - 1163.en_US
dc.identifier.endpage1163en_US
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-85075854625
dc.identifier.scopusqualityQ3
dc.identifier.startpage1157en_US
dc.identifier.trdizinid339094
dc.identifier.urihttps://hdl.handle.net/20.500.12939/2833
dc.identifier.volume23en_US
dc.identifier.wosWOS:000497661000020
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorAksoy, Nilay
dc.language.isoen
dc.relation.ispartofJournal of research in pharmacy
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectWarfarinen_US
dc.subjectAnticoagulationen_US
dc.subjectMonitoringen_US
dc.subjectClinical Pharmacisten_US
dc.titleThe role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment
dc.typeArticle

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu
Eczacılık Fakültesi Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu